Loading...
Market
Story
US to Pay Moderna $176 Million for Pandemic Flu Vaccine Amid Bird Flu Concerns
Jul 8, 2024, 06:58 PM
The US government has agreed to pay Moderna $176 million to develop a pandemic flu vaccine. This move comes as part of a broader effort to prepare for potential future pandemics, including bird flu. Finland and fourteen other EU countries have also signed up to procure bird-flu vaccines. Additionally, Moderna and Mitsubishi Tanabe Pharma have entered a joint agreement to promote Moderna’s mRNA respiratory vaccine portfolio in Japan, which includes COVID-19 vaccines. Concerns are rising about the H5N2 and H5N1 viruses, with the NIAID involved in related research.
View original story
Similar markets
Less than 1 million • 25%
1-5 million • 25%
5-10 million • 25%
More than 10 million • 25%
United States • 25%
Canada • 25%
United Kingdom • 25%
Other • 25%
Limited to 1-5 countries • 25%
Spread to 6-10 countries • 25%
Spread to 11-20 countries • 25%
Spread to 21+ countries • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
Pfizer • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
No partnership announced • 25%
Moderna • 25%
Sinergium Biotech • 25%
Pfizer • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16+ countries • 25%